Characterising the scale-up and performance of antiretroviral therapy programmes in sub-Saharan Africa: an observational study using growth curves

被引:0
|
作者
Bigelow, Benjamin [1 ]
Verguet, Stephane [1 ]
机构
[1] Harvard TH Chan Sch Publ Hlth, Global Hlth & Populat, Boston, MA 02115 USA
来源
BMJ OPEN | 2020年 / 10卷 / 09期
关键词
public health; health policy; health economics; HIV & AIDS; MIDDLE-INCOME; HEALTH; MORTALITY; DECLINE; COUNTRIES; SYSTEMS;
D O I
10.1136/bmjopen-2019-034973
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The rate of change in key health indicators (eg, intervention coverage) is an understudied area of health system performance. Rates of change in health services indicators can augment traditional measures that solely involve the absolute level of performance in those indicators. Growth curves are a class of mathematical models that can parameterise dynamic phenomena and estimate rates of change summarising these phenomena; however, they are not commonly used in global health. We sought to characterise the changes over time in antiretroviral therapy (ART) coverage in sub-Saharan Africa using growth curve models. Design This was a retrospective observational study. We used publicly available data on ART coverage levels from 2000 to 2017 in 42 sub-Saharan African countries. We developed two ordinary differential equations models, the Gompertz and logistic growth models, that allowed for the estimation of summary parameters related to scale-up and rates of change in ART coverage. We fitted non-linear regressions for the two models, assessed goodness of fit using the Bayesian information criterion (BIC), and ranked countries based on their estimated performance drawn from the fitted model parameters. Results We extracted country performance in rates of scale-up of ART coverage, which ranged from <= 2.5 percentage points per year (South Sudan, Sudan, and Madagascar) to >= 8.0 percentage points per year (Benin, Zimbabwe and Namibia), using the Gompertz model. Based on BIC, the Gompertz model provided a better fit than the logistic growth model for most countries studied. Conclusions Growth curve models can provide benchmarks to assess country performance in ART coverage evolution. They could be a useful approach that yields summary metrics for synthesising country performance in scaling up key health services.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review
    Barth, Roos E.
    van der Loeff, Maarten F. Schim
    Schuurman, Rob
    Hoepelmon, Andy I. M.
    Wensing, Annemarie M. J.
    LANCET INFECTIOUS DISEASES, 2010, 10 (03): : 155 - 166
  • [22] HIV knowledge trends during an era of rapid antiretroviral therapy scale-up: an analysis of 33 sub-Saharan African countries
    Chan, Brian T.
    Tsai, Alexander C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 (07)
  • [23] Reconsidering the impact of conflict on HIV infection among women in the era of antiretroviral treatment scale-up in sub-Saharan Africa: a gender lens
    Shannon, Kate
    Kaida, Angela
    Rachlis, Beth
    Lloyd-Smith, Elisa
    Gray, Glenda
    Strathdee, Steffanie A.
    AIDS, 2008, 22 (14) : 1705 - 1707
  • [24] Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
    Lawn, Stephen D.
    Harries, Anthony D.
    Anglaret, Xavier
    Myer, Landon
    Wood, Robin
    AIDS, 2008, 22 (15) : 1897 - 1908
  • [25] Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies
    Davies, Mary-Ann
    Egger, Matthias
    Keiser, Olivia
    Boulle, Andrew
    AJAR-AFRICAN JOURNAL OF AIDS RESEARCH, 2009, 8 (03): : 329 - 338
  • [26] Response to: defaulting from antiretroviral treatment programmes in sub-Saharan Africa: a problem of definition
    Fox, Matthew P.
    Rosen, Sydney B.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 (03) : 392 - 392
  • [27] No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa
    Gill, CJ
    Hamer, DH
    Simon, JL
    Thea, DA
    Sabin, LL
    AIDS, 2005, 19 (12) : 1243 - 1249
  • [28] Adherence without access to antiretroviral therapy in sub-Saharan Africa? Reply
    Gill, CJ
    Hamer, DH
    Simon, JL
    Thea, DM
    Sabin, LL
    AIDS, 2006, 20 (01) : 141 - 142
  • [29] Challenges and perspectives of compliance with pediatric antiretroviral therapy in Sub-Saharan Africa
    Dahourou, D. L.
    Leroy, V.
    MEDECINE ET MALADIES INFECTIEUSES, 2017, 47 (08): : 511 - 518
  • [30] Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa
    Harries, Anthony D.
    Zachariah, Rony
    Lawn, Stephen D.
    Rosen, Sydney
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 : 70 - 75